Cipla
ProfileJobs

Cipla

Suggest Edit
    • Healthbiotechdrug developmentpharma

    Cipla is a global pharmaceutical company, which offers active pharmaceutical ingredients and formulations in various therapeutic areas, such as women’s health, cardiovascular, children’s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, oncology, infectious diseases and critical care, malaria, neurosciences, ophthalmology, osteoporosis, respiratory, and urology. The Company also provides veterinary products, including anti-infectives, anti-inflammatories, anti-thyroids, immunosuppressants, parasiticides, nutraceuticals, and feed additives for various animals.

    Type
    Public
    HQ
    Mumbai, IN
    Founded
    1935
    Size (employees)
    23,043 (est)
    Website
    cipla.com
    Cipla was founded in 1935 and is headquartered in Mumbai, IN
    Report incorrect company information

    Key People/Management at Cipla

    Umang Vohra

    Umang Vohra

    CEO
    Kedar Upadhye

    Kedar Upadhye

    Global CFO
    Ranjana Pathak

    Ranjana Pathak

    Global Head - Quality
    Geena Malhotra

    Geena Malhotra

    Global Head - Integrated Product Development
    Prabir Jha

    Prabir Jha

    President & Global CPO
    Raju Subramanyam

    Raju Subramanyam

    Global Head - Operations

    Cipla Office Locations

    Cipla has offices in South Melbourne, Central Islip, Sunrise, Windhoek and in 6 other locations
    Mumbai, IN (HQ)
    Ganpatrao Kadam Marg
    Hyderabad, IN
    Karvy Selenium Tower B, Plot No.: 31 & 32 Gachibowli
    South Melbourne, AU
    1 132-136 Albert Rd
    Windhoek, NA
    12 Gold Street, Office No C12 Warehouse 1
    Cape Town, ZA
    9 Mispel Street
    East London, ZA
    14 Stewart Dr
    Show all (10)
    Report incorrect company information

    Competitors

    Par Pharmaceutical
    Health - Subsidiary
    Mylan
    Health - Public
    Dr. Reddy's Laboratories
    Health - Public
    MyoKardia
    Health - Public
    Compare competitors

    Cipla Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Cipla News and Updates

    May 09, 2018

    MannKind's (MNKD) CEO Michael Castagna on Q1 2018 Results - Earnings Call Transcript

    May 09, 2018

    MannKind Inks Afrezza Deal With Cipla For India

    May 02, 2018

    Antitussives Market – Growth, Future Prospects and Competitive Analysis, 2018 - 2026 - Credence Research

    As per the latest research citing of the European Respiratory Journal 2016 report, the global prevalence rate of cough was 9.6%. The largest prevalence was in the Oceania region with 18.1% followed by Europe, America, Asia and Africa with 12.7%, 11.0%, 4.4% and 2.3% respectively. Cough is basically …
    March 06, 2018

    Global Peptides Market Report 2018: By Product, Application, Manufacturer, Sales and Segmentation – Global QYResearch

    "Global Peptides Market Professional Survey Report 2018" is the latest addition to Global QYResearch industry research reports collection. Posted via Industry Today. Follow us on Twitter @IndustryToday
    February 15, 2018

    Global Malaria Drugs Market 2018 Key Players: Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche.

    WiseGuyReports.com adds “Malaria Drugs Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025”reports to its database. Posted via Industry Today. Follow us on Twitter @IndustryToday
    December 13, 2017

    Asia Pacific Alopecia Treatment Market to Raise at a CAGR of 6.6% by 2024

    Growth of the alopecia treatment market is mainly driven by increasing demand for hair loss treatment drugs with enhanced effectiveness and minimal side effects. Posted via Industry Today. Follow us on Twitter @IndustryToday
    Show more
    Report incorrect company information
    Download PDF